CIK: 0001839435 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $482,813 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 1,256,265 | $79,396 | 16.4% | $47.54 | +8.5% | COM | 03753U106 |
| NBP | I MAB | 943,156 | $79,178 | 16.4% | $63.37 | — | SPONSORED ADS | 44975P103 |
| — | CURIS INC | 3,582,629 | $28,912 | 6.0% | $8.14 | — | COM NEW | 231269200 |
| BBIO | BRIDGEBIO PHARMA INC | 380,928 | $23,221 | 4.8% | $57.11 | 0.0% | COM | 10806X102 |
| RCUS | ARCUS BIOSCIENCES INC | 760,164 | $20,874 | 4.3% | $27.66 | +3.3% | COM | 03969F109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 831,267 | $20,017 | 4.1% | $35.47 | -13.7% | COM | 35104E100 |
| ZLAB | ZAI LAB LTD | 109,335 | $19,351 | 4.0% | $176.99 | — | ADR | 98887Q104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 561,398 | $18,773 | 3.9% | $18.00 | +52.5% | COM NEW | 15117B202 |
| VERA | VERA THERAPEUTICS INC | 1,132,671 | $15,008 | 3.1% | $15.54 | 0.0% | CL A | 92337R101 |
| — | ACCELERON PHARMA INC | 112,363 | $14,100 | 2.9% | $127.94 | — | COM | 00434H108 |
| ARVN | ARVINAS INC | 178,500 | $13,745 | 2.8% | $34.48 | +101.3% | COM | 04335A105 |
| DYN | DYNE THERAPEUTICS INC | 583,649 | $12,280 | 2.5% | $19.71 | -4.6% | COM | 26818M108 |
| IPSC | CENTURY THERAPEUTICS INC | 403,523 | $11,839 | 2.5% | $25.37 | 0.0% | COM | 15673T100 |
| GOSS | GOSSAMER BIO INC | 1,413,138 | $11,475 | 2.4% | $9.85 | -12.0% | COM | 38341P102 |
| RNAM | AVIDITY BIOSCIENCES INC | 446,641 | $11,036 | 2.3% | $28.99 | -19.7% | COM | 05370A108 |
| STOK | STOKE THERAPEUTICS INC | 296,822 | $9,991 | 2.1% | $35.35 | 0.0% | COM | 86150R107 |
| — | AMBRX BIOPHARMA INC | 450,000 | $8,820 | 1.8% | $19.60 | — | SPONSORED ADS | 02290A102 |
| PMVP | PMV PHARMACEUTICALS INC | 250,000 | $8,540 | 1.8% | $39.23 | -14.9% | COM | 69353Y103 |
| — | CONNECT BIOPHARMA HLDGS LTD | 373,492 | $7,294 | 1.5% | $18.50 | — | ADS | 207523101 |
| TSHA | TAYSHA GENE THERAPIES INC | 320,440 | $6,793 | 1.4% | $21.54 | +7.0% | COM SHS | 877619106 |
| CRDF | CARDIFF ONCOLOGY INC | 982,753 | $6,535 | 1.4% | $14.50 | -41.5% | COM | 14147L108 |
| — | IKENA ONCOLOGY INC | 400,000 | $5,616 | 1.2% | $28.25 | — | COM | 45175G108 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 238,045 | $5,404 | 1.1% | $20.37 | 0.0% | COM | 61225M102 |
| DSGN | DESIGN THERAPEUTICS INC | 250,000 | $4,973 | 1.0% | $31.14 | -19.0% | COM | 25056L103 |
| — | PROMETHEUS BIOSCIENCES INC | 200,000 | $4,912 | 1.0% | $18.26 | — | COM | 74349U108 |
| KYMR | KYMERA THERAPEUTICS INC | 100,000 | $4,850 | 1.0% | $43.41 | 0.0% | COM | 501575104 |
| — | MERUS N V | 206,927 | $4,360 | 0.9% | $20.90 | — | COM | N5749R100 |
| — | IVERIC BIO INC | 680,036 | $4,291 | 0.9% | $6.91 | — | COM | 46583P102 |
| MLTX | HELIX ACQUISITION CORP | 400,000 | $4,132 | 0.9% | $11.37 | — | COM CL A | G4444C102 |
| RVMD | REVOLUTION MEDICINES INC | 126,136 | $4,004 | 0.8% | $39.54 | -11.7% | COM | 76155X100 |
| — | NGM BIOPHARMACEUTICALS INC | 200,000 | $3,944 | 0.8% | $29.53 | — | COM | 62921N105 |
| — | KRONOS BIO INC | 146,173 | $3,501 | 0.7% | $29.87 | — | COM | 50107A104 |
| — | JIYA ACQUISITION CORP | 300,000 | $2,982 | 0.6% | $10.30 | — | COM CL A | 47760M102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 125,000 | $2,666 | 0.6% | $32.43 | -15.7% | COM | 28036F105 |